Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 19, 2021

Primary Completion Date

March 25, 2024

Study Completion Date

March 25, 2024

Conditions

Breast CarcinomaInvasive Breast Carcinoma

Interventions

PROCEDURE

Contrast-Enhanced Mammography

Undergo CEM

PROCEDURE

Digital Tomosynthesis Mammography

Undergo DBT

OTHER

Electronic Health Record Review

Medical records reviewed

DRUG

Iodinated Contrast Agent

Given IV

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER

NCT05036083 - Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion | Biotech Hunter | Biotech Hunter